Inhibiting proliferation of gefitinib-resistant, non-small cell lung cancer

被引：0

作者：

Makoto Sudo

Tan Min Chin

Seiichi Mori

Ngan B. Doan

Jonathan W. Said

Makoto Akashi

H. Phillip Koeffler

机构：

[1] National University of Singapore,Cancer Science Institute

[2] National University Hospital,Department of Hematology and Oncology

[3] The Cancer Institute,Department of Cancer Genomics

[4] Japanese Foundation for Cancer Research,Department of Pathology and Laboratory Medicine

[5] University of California,Research Center for Radiation Emergency

[6] National Institute of Radiological Sciences,Division of Hematology and Oncology

[7] Cedars-Sinai Medical Center,undefined

来源：

Cancer Chemotherapy and Pharmacology | 2013年 / 71卷

关键词：

Non-small cell lung cancer (NSCLC); Tyrosine kinase inhibitor (TKI); EGFR; 17-DMAG; Belinostat; Combination chemotherapy;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1325 / 1334

页数：9

共 50 条

[11] Antitumor Activity of a Bispecific Chimera Targeting EGFR and Met in Gefitinib-Resistant Non-Small Cell Lung Cancer
Wang, Ya
Zhang, Guixi
Zhou, Zhilan
Zhang, Ning
Jiang, Hang
Liu, Yichang
Fu, Ting
Zhu, Yingdi
Li, Juan
ADVANCED HEALTHCARE MATERIALS, 2025, 14 (02)
[12] Overexpression and extended degradation rate of Axl in acquired gefitinib-resistant non-small cell lung cancer cells
Kim, Donghwa
Bach, Duc-Hiep
Hong, Ji-Young
Park, Hyen Joo
Lee, Sang Kook
CANCER RESEARCH, 2018, 78 (13)
[13] The role of salvage surgery in the treatment of a gefitinib-resistant non-small cell lung cancer patient: a case report
Zang, Jing
Horinouchi, Hidehito
Hanaoka, Jun
Funai, Kazuhito
Sakakura, Noriaki
Liao, Hu
JOURNAL OF THORACIC DISEASE, 2021, 13 (07) : 4554 - 4559
[14] Role of adenosine A2a receptors in the growth control of a gefitinib-resistant non-small cell lung cancer cell growth
Noguchi, Maki
Kuzumaki, Naoko
Nagasawa, Atsumi
Narita, Michiko
Narita, Minoru
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2013, 121 : 197P - 197P
[15] Combination Effect between Bortezomib and Tumor Necrosis Factor α on Gefitinib-resistant Non-small Cell Lung Cancer Cell Lines
Kusumoto, Sojiro
Sugiyama, Tomohide
Ando, Koichi
Hosaka, Takamichi
Ishida, Hiroo
Shirai, Takao
Yamaoka, Toshimitsu
Okuda, Kentaro
Hirose, Takashi
Ohnishi, Tsukasa
Inoue, Fumiko
Kanome, Tomoko
Kadofuku, Tsuyoki
Saijo, Nagahiro
Adachii, Mitsuru
Ohmori, Tohru
ANTICANCER RESEARCH, 2009, 29 (06) : 2315 - 2322
[16] Deoxypodophyllotoxin Inhibits Cell Growth and Induces Apoptosis by Blocking EGFR and MET in Gefitinib-Resistant Non-Small Cell Lung Cancer
Kim, Han Sol
Oh, Ha-Na
Kwak, Ah-Won
Kim, Eunae
Lee, Mee-Hyun
Seo, Ji-Hye
Cho, Seung-Sik
Yoon, Goo
Chae, Jung-Il
Shim, Jung-Hyun
JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 2021, 31 (04) : 559 - 569
[17] Short-hairpin RNA library: identification of therapeutic partners for gefitinib-resistant non-small cell lung cancer
Sudo, Makoto
Mori, Seiichi
Madan, Vikas
Yang, Henry
Leong, Geraldine
Koeffler, H. Phillip
ONCOTARGET, 2015, 6 (02) : 814 - 824
[18] Targeting the degradation of AXL receptor tyrosine kinase to overcome resistance in gefitinib-resistant non-small cell lung cancer
Bae, Song Yi
Hong, Ji-Young
Lee, Hye-Jung
Park, Hyen Joo
Lee, Sang Kook
ONCOTARGET, 2015, 6 (12) : 10146 - 10160
[19] Antitumor Impact of p14ARF on Gefitinib-Resistant Non-Small Cell Lung Cancers
Saito, Ken
Takigawa, Nagio
Ohtani, Naoko
Iioka, Hidekazu
Tomita, Yuki
Ueda, Ryuzo
Fukuoka, Junya
Kuwahara, Kazuhiko
Ichihara, Eiki
Kiura, Katsuyuki
Kondo, Eisaku
MOLECULAR CANCER THERAPEUTICS, 2013, 12 (08) : 1616 - 1628
[20] Jatrorrhizine Exhibits an Antitumor Effect Against Gefitinib-resistant Non-small Cell Lung Cancer via Inhibiting PI3K/mTOR Phosphorylation
Yao, Kainan
Li, Zeli
Muhetaer, Gulizeba
Guan, Huiting
Su, Ming
Zhang, Li
Liang, Jian
Li, Hang
Zhou, Jihong
CHEMISTRY & BIODIVERSITY, 2025,

← 1 2 3 4 5 →